| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |